You searched for "laser"
Lost and sound: exploring hyperbaric oxygen therapy for refractory SSNHL
Can hyperbaric oxygen therapy (HBOT) offer a breakthrough for patients with refractory sudden sensorineural hearing loss (SSNHL)? SSNHL is defined as acute hearing loss of ≥30 decibels in three consecutive frequencies within three days. Typically, it’s treated with two weeks...
Management of post-tonsillectomy bleeding with nebulised TXA
In the last 20 years, rates of adult tonsillectomy have fallen in the order of 50%. The flipside to this, is that the number of admissions of patients with acute tonsilitis is more than double the reduction in tonsillectomy rates....
Patients with severe uncontrolled CRSwNP respond to biologics in the real world
Clinical trials have demonstrated that biologics are effective in treating patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This multicentre (15 tertiary care centres in France) observational prospective cohort study aims to examine the effectiveness of biologics in treating CRSwNP...Landmark study at Homerton University Hospital confirms GastroPanel®’s diagnostic accuracy
BIOHIT HealthCare is pleased to announce that a clinical study conducted by Homerton University Hospital NHS Foundation Trust, London, has confirmed the diagnostic accuracy of GastroPanel in identifying gastric cancer risk in patients with upper abdominal complaints. This study demonstrated...BIOHIT introduces the FAEX™ Sample System for stool sample collection and handling
BIOHIT OYJ is excited to announce the launch of the BIOHIT FAEX Sample System, a revolutionary stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic workflow. Designed for precision, efficiency and flexibility, this innovative, practical...MED-EL showcases global commitment to hearing health at World EXPO 2025 Osaka
At the heart of the Austrian Pavilion at World EXPO 2025, MED-EL is bringing hearing health to the global stage. Selected from over 150 applicants, MED-EL has been featured since April in Austria’s Innovation Lab, where an infomercial highlights how...Navient receives FDA 510(k) clearance for ENT procedures
CKI (ClaroNav Kolahi Inc.) has received FDA 510(k) clearance for Navient in ENT procedures, expanding its previous clearance for cranial applications. Navient is now approved by major global regulatory bodies, including Canada (HC), Europe (EU MDD), China (NMPA), UAE, Saudi...
Paroxysmal downbeating nystagmus and proton pump inhibitors
This case report highlights the effect of long-term use of proton pump inhibitors on the vestibular system. The authors reported a case of a 70-year-old woman who was admitted with delirium, ataxia, slurred speech and slowness of thought. She had...
Bevacizumab, NF2, hearing and age
Introduction NF2-related schwannomatosis (NF2-SWN) is an autosomal dominant disorder leading to the development of schwannomas, meningiomas and spinal cord ependymomas. Younger age is a negative prognostic factor. Treatment includes observation, surgery, radiotherapy and medical therapy with bevacizumab (VEGF monoclonal antibody)....
